Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

被引:235
|
作者
Bearcroft, CP
Perrett, D
Farthing, MJG
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Med, London E1 2AD, England
[2] Digest Dis Res Ctr, London E1 2AD, England
关键词
5-hydroxytryptamine; postprandial; diarrhoea predominant irritable bowel syndrome;
D O I
10.1136/gut.42.1.42
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Increased concentrations of 5-hydroxytryptamine (5-HT) can be detected in the systemic circulation after a meal and may be involved in the physiological control of gastrointestinal motility. Abnormalities of 5-HT release after a meal might explain some of the postprandial symptoms associated with the irritable bowel syndrome (IBS). Aim-To investigate the effect of a standard meal on plasma 5-HT and urinary 5-hydroxyindole acetic acid (5-HIAA) concentrations in patients with diarrhoea predominant IBS and in healthy volunteers. Methods-After an overnight fast, six volunteers and five patients with IBS were given a carbohydrate-rich meal. Blood and urine samples were taken before and for four hours after the meal. Platelet-poor plasma 5-HT and urinary 5-HIAA were analysed by reversed phase high performance liquid chromatography with fluorometric detection. 5-HIAA was expressed as a ratio with urinary creatinine concentration, which was measured by spectrophotometry. Results-During the four hour postprandial period, 5-HT concentrations were significantly higher in patients with IBS than in healthy volunteers at 0.5 hours (p<0.05), 2 hours (p<0.05) and 2.5 hours (p<0.05). 5-HT was not detected in the plasma in the fasting state in patients or volunteers. Median peak 5-HT in patients with IBS (359 (198-796) nmol/l) was significantly greater than volunteers (83 (7-190)) (p<0.05). "Area under the curve)) for 5-HT detection was greater for patients with IBS (317 (138-771)) than for healthy volunteers (51 (4-129); p<0.05). The duration of the 5-HT peak was significantly longer in patients with IBS (3 (1-3) hours) than in the healthy volunteers (1 (1-1) hours; p<0.01). Postprandial urinary median 5-HIAA values in controls (5.6 (5.5-5.8) mu mol/mmol creatinine) and patients with IBS: (3.0 (2.5-6.8) mu mol/mmol creatinine) were not significantly different from preprandial Dentistry values (controls: 5.9 (5.5-6.6) mu mol/mmol creatinine; patients with IBS: (6.2 (2.4- 9.3) mu mol/mmol creatinine). Conclusion-These findings indicate that there may be a difference in the way that 5-HT is released in patients with diarrhoea predominant IBS, and could suggest a possible role for 5-HT in the postprandial symptoms of these patients.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
  • [21] 5-hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: Molecular connections
    Galligan, JJ
    GASTROENTEROLOGY, 2004, 126 (07) : 1897 - 1899
  • [22] Plasma 5-hydroxytryptamine concentration varies with gender and menstrual status in irritable bowel syndrome patients with diarrhoea (IBS-D) but not healthy volunteers
    Houghton, Lesley A.
    Perry, Heather
    Morris, Julie
    Whorwell, Peter J.
    Keevil, Brian
    GASTROENTEROLOGY, 2008, 134 (04) : A681 - A681
  • [23] Plasma 5-hydroxytryptamine concentration varies with gender and menstrual status in irritable bowel syndrome patients with diarrhoea JBS-D) but not healthy volunteers
    Houghton, Lesley A.
    Perry, Heather
    Fell, Catherine
    Atkinson, Wendy
    Whorwell, Peter J.
    Keevil, Brian
    Morris, Julie
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 : 61 - 61
  • [24] A postprandial distal colonic motor abnormality exists in patients with diarrhoea predominant irritable bowel syndrome (IBS)
    Rosli, R. Mohd
    Kumar, R.
    Wiklendt, L.
    Wattchow, D.
    Fraser, R.
    Arkwright, J.
    Maslen, L.
    Bampton, P.
    Dinning, P.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [25] Review of Acupuncture for Irritable Bowel Syndrome with predominant Diarrhoea Symptoms and functional Diarrhoea
    Wiebrecht, Axel
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2021, 64 (01): : 85 - 86
  • [26] Eluxadoline for the treatment of diarrhoea- predominant irritable bowel syndrome
    Scarpellini, Emidio
    Laterza, Lucrezia
    Ianiro, Gianluca
    Tack, Jan
    Abenavoli, Ludovico
    Gasbarrini, Antonio
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1395 - 1402
  • [27] Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome
    Keating, Gillian M.
    DRUGS, 2017, 77 (09) : 1009 - 1016
  • [28] Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome
    Laterza, Lucrezia
    Ianiro, Gianluca
    Scoleri, Iolanda
    Landi, Rosario
    Bruno, Giovanni
    Scaldaferri, Franco
    Gaetani, Eleonora
    Campanale, Mariachiara
    Gasbarrini, Antonio
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 607 - 615
  • [29] The Role of Serum Chromogranin A in Diarrhoea Predominant Irritable Bowel Syndrome
    Sidhu, Reena
    McAlindon, Mark E.
    Leeds, John S.
    Skilling, Jessica
    Sanders, David S.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (01) : 23 - 26
  • [30] Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome
    Gillian M. Keating
    Drugs, 2017, 77 : 1009 - 1016